Approved by the MHRA, Cabotegravir 600 mg long-acting injection is the first injectable treatment approved to help prevent HIV-1 infection in the UK
In a...
MHRA's latest initiative aims to empower consumers in the fight against online pharmacy frauds
The Medicines and Healthcare products Regulatory Agency (MHRA) is doubling down...
MHRA's strategic principles aim to foster innovation while upholding rigorous standards of patient safety and regulatory integrity
In a recent announcement the Medicines and Healthcare...
People are warned that use of unbranded devices could exacerbate the situation by pushing obstructions further down into the airway passageÂ
The Medicines and Healthcare...
Studies showed that 26% of those who received the once-daily tablet achieved clinical remission after 12 weeks of treatment. Â Â
American pharmaceutical giant Pfizer has...